Parkside Financial Bank & Trust

Bank

Position in VKTX — Viking Therapeutics, Inc.

CIK 1455267 SAINT LOUIS, MO

Position in VKTX

as of Jun 30, 2026 · filed Sep 4, 2026 Compact

Position Value

$89,801

+$14,634 QoQ

Shares Held

2,302

-0.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 17% Shared 0% None 83%

Healthcare · as of Jun 30, 2026

Parkside Financial Bank & Trust holds $49,351,632 across 127 Biotechnology names. VKTX ranks #8 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	1,329,158	$47,038,901
2	HALO	Halozyme Therapeutics, Inc.	5,790	$453,182
3	VRTX	Vertex Pharmaceuticals Inc / Ma	759	$377,017
4	TECH	BIO-TECHNE Corp	3,596	$254,056
5	MRNA	Moderna, Inc.	1,774	$124,233
6	REGN	Regeneron Pharmaceuticals, Inc.	167	$104,131
7	DNTH	Dianthus Therapeutics, Inc. /DE/	1,050	$102,354
8	VKTX	Viking Therapeutics, Inc. This page	2,302	$89,801

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$89,801	2,302	-0.3%	Shares	Sole	2026-09-04
2026-03-31	$75,167	2,310	+0.3%	Shares	Sole	2026-05-13
2025-12-31	$81,018	2,303	+2.3%	Shares	Sole	2026-02-13
2025-09-30	$59,156	2,251	+75.7%	Shares	Sole	2025-10-30
2025-06-30	$33,946	1,281	+0.2%	Shares	Sole	2025-08-07
2025-03-31	$30,863	1,278	+46.2%	Shares	Sole	2025-05-08
2024-12-31	$35,169	874	-0.6%	Shares	Sole	2025-02-05
2024-09-30	$55,649	879	+0.6%	Shares	Sole	2024-11-07
2024-06-30	$46,330	874	+4.7%	Shares	Sole	2024-08-05
2024-03-31	$68,470	835	+178.3%	Shares	Sole	2024-05-01
2023-12-31	$5,583	300	0.0%	Shares	Sole	2024-02-01
2023-09-30	$3,321	300	0.0%	Shares	Sole	2023-11-13
2023-06-30	$4,863	300	+50.0%	Shares	Sole	2023-08-15
2023-03-31	$3,330	200	—	Shares	Sole	2023-05-04
No filing history on record for this holder in this stock.